from ALS patients, advocates and members of Congress. In recent weeks the agency received more than 1,300 written comments from the ALS community supporting the treatment.
The powder-based drug is a combination of two older ingredients: a prescription medication for liver disorders and a dietary supplement associated with traditional Chinese medicine. Cambridge, Massachusetts-based Amylyx has patented the combination and says the chemicals work together to shield cells from premature death.
Amylyx did not immediately disclose the price Thursday but said it planned to announce the information on a call with investors Friday morning. In Canada, where the drug received approval in June, the company has proposed a price equating to $165,000. Sunny Brous was diagnosed with ALS in 2015 and hopes to add Relyvrio to the two older FDA-approved medications she already takes for the disease.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Much-debated drug from Amylyx for Lou Gehrig’s disease wins FDA approvalA much-debated drug for Lou Gehrig’s disease won U.S. approval on Thursday from the Food and Drug Administration. Wdc
Source: FOX10Phoenix - 🏆 83. / 68 Read more »
Despite Questionable Data, Drug for Lou Gehrig’s Disease Wins FDA ApprovalA much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.
Source: NBCNewYork - 🏆 270. / 63 Read more »
New drug to treat ALS-Lou Gehrig's disease partially funded by Ice Bucket ChallengeDousing yourself or someone else in ice-cold water started on social media eight years ago. The ALS Association received $115 million in donations.
Source: fox32news - 🏆 547. / 51 Read more »
ALS drug wins FDA approval despite questionable dataWASHINGTON (AP) — A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines. Now make it affordable Which one of those men there is Lou Gehrig, and why does he have a disease? What did Lou Gehrig die of? How did he not see that coming?
Source: AP - 🏆 728. / 51 Read more »